Elevated circulating levels of CCL2, CCL3, CCL4, and CCL5 have been reported in patients with osteoporosis, suggesting that excessive chemokine signaling may enhance osteoclast recruitment and inflammatory bone resorption. This evidence concerns the gene CCL2 and osteoporosis.